About Veryan Medical
Veryan Medical is a company based in Horsham (United Kingdom) founded in 2003.. Veryan Medical has raised $40.8 million across 3 funding rounds from investors including Seven Mile Capital Partners, Imperial Innovations and Seroba Lifesciences. The company has 35 employees as of December 31, 2020. Veryan Medical offers products and services including BioMimics 3D Vascular Stent System. Veryan Medical operates in a competitive market with competitors including SMT, InspireMD, Vesper Medical, Endospan and Biosensors International, among others.
- Headquarter Horsham, United Kingdom
- Employees 35 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Veryan Medical Limited
- Date of Incorporation 10 Jun, 2003
- Jurisdiction OXFORD, OXFORDSHIRE
-
Annual Revenue
$15.1 M (USD)92as on Dec 31, 2019
-
Net Profit
$-15.09 M (USD)-82as on Dec 31, 2019
-
EBITDA
$-15.09 M (USD)-82as on Dec 31, 2019
-
Total Equity Funding
$40.8 M (USD)
in 3 rounds
-
Latest Funding Round
$27.4 M (USD), Series B
Jan 15, 2015
-
Investors
Seven Mile Capital Partners
& 4 more
-
Employee Count
35
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Veryan Medical
Veryan Medical offers a comprehensive portfolio of products and services, including BioMimics 3D Vascular Stent System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Stent with helical design to improve arterial blood flow
Funding Insights of Veryan Medical
Veryan Medical has successfully raised a total of $40.8M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $27.4 million completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $27.4M
-
First Round
First Round
(12 Mar 2010)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2015 | Amount | Series B - Veryan Medical | Valuation |
investors |
|
| Oct, 2011 | Amount | Series B - Veryan Medical | Valuation |
investors |
|
| Mar, 2010 | Amount | Series A - Veryan Medical | Valuation | Imperial Innovations , Oxford Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Veryan Medical
Veryan Medical has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Seven Mile Capital Partners, Imperial Innovations and Seroba Lifesciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in startups are focused on Europe and the US.
|
Founded Year | Domain | Location | |
|
Private equity investments are focused on US markets.
|
Founded Year | Domain | Location | |
|
Early-stage venture capital is invested in UK technology sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Veryan Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Veryan Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Veryan Medical Comparisons
Competitors of Veryan Medical
Veryan Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SMT, InspireMD, Vesper Medical, Endospan and Biosensors International, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
SMT is recognized as a developer of cardiovascular medical devices.
|
|
| domain | founded_year | HQ Location |
Proprietary stent systems with bio-stable mesh are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Venous stent system is developed for deep vein disease treatment.
|
|
| domain | founded_year | HQ Location |
Endovascular stent graft systems for aortic aneurysm repair are developed.
|
|
| domain | founded_year | HQ Location |
Products for interventional cardiology and critical care procedures
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Veryan Medical
Frequently Asked Questions about Veryan Medical
When was Veryan Medical founded?
Veryan Medical was founded in 2003 and raised its 1st funding round 7 years after it was founded.
Where is Veryan Medical located?
Veryan Medical is headquartered in Horsham, United Kingdom. It is registered at Horsham, West Sussex, United Kingdom.
Is Veryan Medical a funded company?
Veryan Medical is a funded company, having raised a total of $40.8M across 3 funding rounds to date. The company's 1st funding round was a Series A of $5.4M, raised on Mar 12, 2010.
How many employees does Veryan Medical have?
As of Dec 31, 2020, the latest employee count at Veryan Medical is 35.
What is the annual revenue of Veryan Medical?
Annual revenue of Veryan Medical is $15.1M as on Dec 31, 2019.
What does Veryan Medical do?
Veryan Holdings is a a clinical-stage medical device company focused on a three dimensional vascular stent for peripheral vascular disease. It was founded as a technology spin-out from Imperial College, London. Veryan shareholders include Imperial Innovations Group, Seroba Kernel, Oxford Capital Partners, Seven Mile Capital Partners, and National Endowment for Science and Arts. The product received the CE Mark in 2012, but is not yet approved for use in the US. Veryan has partnered with Biosensors International for distribution.
Who are the top competitors of Veryan Medical?
What products or services does Veryan Medical offer?
Veryan Medical offers BioMimics 3D Vascular Stent System.
Who are Veryan Medical's investors?
Veryan Medical has 5 investors. Key investors include Seven Mile Capital Partners, Imperial Innovations, Seroba Lifesciences, Oxford Capital, and Nesta Impact Investments.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.